Onco3R

Onco3R is a French preclinical contract research organization (CRO) specializing in oncology, radiotherapy, and DNA damage repair (DDR). Based in the Toulouse Oncopole, the company provides specialized services to evaluate the efficacy and safety of new therapeutic agents, with a specific focus on radiosensitization and overcoming treatment resistance. Their platform includes advanced 2D and 3D cell culture models, specialized DNA repair assays such as the Comet assay, and high-precision irradiation capabilities. Onco3R supports pharmaceutical and biotech partners in developing therapies that target the DNA damage response and optimizing the synergy between drugs and radiotherapy. The company acts as a strategic partner for the preclinical validation of oncology candidates intended for combination therapy.